Related Experiment Video
Updated: Mar 29, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Clinical outcomes of the glued intraocular lens scaffold
Priya Narang1, Amar Agarwal1, Dhivya A Kumar1
1From the Narang Eye Care and Laser Centre (Narang), Ahmedabad, and Dr. Agarwal's Eye Hospital and Eye Research Centre (Amar Agarwal, Kumar, Ashvin Agarwal), Chennai, India.
Purpose:
To report the visual outcomes and complications of the glued intraocular lens (IOL) scaffold procedure in patients with intraoperative posterior capsule rupture and retained nuclear fragments, subluxated cataract, and Soemmerring ring associated with aphakia and deficient posterior capsule.
Setting:
Dr. Agarwal's Eye Hospital, Chennai, India.
Design:
Retrospective noncomparative interventional case series.
Methods:
Medical records of patients who had a glued IOL scaffold procedure performed were reviewed. The main outcome measures were visual acuity at final follow-up and intraoperative and postoperative complications during the entire follow-up.
Results:
The mean preoperative and mean final postoperative corrected distance visual acuity (CDVA) (Snellen decimal equivalent) in 19 eyes of 17 patients were 0.39 ± 0.13 (SD) and 0.73 ± 0.27, respectively (P = .002, Wilcoxon test). No eye lost CDVA. The CDVA was stable in 7 eyes, improved 1 line in 2 eyes, and improved 2 lines or more in 10 eyes. Postoperatively, 20/20 visual acuity was attained in 9 eyes. Intraoperatively, Soemmerring ring drop into the vitreous cavity in 1 eye and hyphema in 2 eyes were observed. Postoperative complications included corneal edema (2 eyes), choroidal detachment (1 eye), mild vitritis (1 eye), ocular hypertension (1 eye), and fibrin reaction in the anterior chamber that resolved with medical management (2 eyes).
Conclusion:
The glued IOL scaffold enabled a closed-chamber approach with proper placement of an IOL in cases with inadequate sulcus or iris support and allowed safe emulsification of the retained nuclear fragments with good visual outcomes.
Financial Disclosure:
No author has a financial or proprietary interest in any material or method mentioned.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

